B. VanScoy

发表

Pharmacokinetics-Pharmacodynamics of CB-618 in Combination with Cefepime, Ceftazidime, Ceftolozane, or Meropenem: the Pharmacological Basis for a Stand-Alone β-Lactamase Inhibitor

S. Bhavnani, P. Ambrose, L. Friedrich, 2017, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics-Pharmacodynamics of a Novel β-Lactamase Inhibitor, CB-618, in Combination with Meropenem in an In Vitro Infection Model

J. McCauley, S. Bhavnani, P. Ambrose, 2016, Antimicrobial Agents and Chemotherapy.

Pharmacokinetic-Pharmacodynamic Characterization of Omadacycline against Haemophilus influenzae Using a One-Compartment In Vitro Infection Model

J. McCauley, S. Bhavnani, P. Ambrose, 2020, Antimicrobial Agents and Chemotherapy.

Gepotidacin Pharmacokinetics-Pharmacodynamics against Escherichia coli in the One-Compartment and Hollow-Fiber In Vitro Infection Model Systems

S. Bhavnani, P. Ambrose, B. VanScoy, 2021, Antimicrobial agents and chemotherapy.

Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Cefepime in an In Vitro Infection Model

D. Livermore, J. McCauley, S. Bhavnani, 2017, Antimicrobial Agents and Chemotherapy.

Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Support Dose Selection for ME1100, an Arbekacin Inhalation Solution

S. Bhavnani, P. Ambrose, J. Hammel, 2020, Antimicrobial Agents and Chemotherapy.

Norepinephrine in Combination with Antibiotic Therapy Increases both the Bacterial Replication Rate and Bactericidal Activity

S. Bhavnani, P. Ambrose, B. VanScoy, 2018, Antimicrobial Agents and Chemotherapy.

Saturability of Granulocyte Kill of Pseudomonas aeruginosa in a Murine Model of Pneumonia

G. Drusano, B. VanScoy, A. Louie, 2011, Antimicrobial Agents and Chemotherapy.

The Use of Streptolysin O for the Treatment of Scars, Adhesions and Fibrosis: Initial Investigations Using Murine Models of Scleroderma

J. McMichael, Ryan G. Rhodes, J. Sauniere, 2004, Nonlinearity in biology, toxicology, medicine.

Differential Effects of Linezolid and Ciprofloxacin on Toxin Production by Bacillus anthracis in an In Vitro Pharmacodynamic System

G. Drusano, B. VanScoy, T. Abshire, 2011, Antimicrobial Agents and Chemotherapy.

Bacterial Replication Rate Modulation in Combination with Antimicrobial Therapy: Turning the Microbe against Itself

J. McCauley, S. Bhavnani, P. Ambrose, 2016, Antimicrobial Agents and Chemotherapy.

Resistance Emergence Mechanism and Mechanism of Resistance Suppression by Tobramycin for Cefepime for Pseudomonas aeruginosa

R. Bonomo, Sarah M. Drawz, B. VanScoy, 2011, Antimicrobial Agents and Chemotherapy.

In Vivo Pharmacokinetics and Pharmacodynamics of APX001 against Candida spp. in a Neutropenic Disseminated Candidiasis Mouse Model

D. Andes, K. Marchillo, P. Ambrose, 2018, Antimicrobial Agents and Chemotherapy.

Pharmacodynamics of a Long-Acting Echinocandin, CD101, in a Neutropenic Invasive-Candidiasis Murine Model Using an Extended-Interval Dosing Design

D. Andes, P. Ambrose, A. Lepak, 2017, Antimicrobial Agents and Chemotherapy.

Evaluation of Ceftolozane-Tazobactam in Combination with Meropenem against Pseudomonas aeruginosa Sequence Type 175 in a Hollow-Fiber Infection Model

A. Oliver, P. Ambrose, J. Horcajada, 2018, Antimicrobial Agents and Chemotherapy.

Efficacy of Ceftolozane-Tazobactam in Combination with Colistin against Extensively Drug-Resistant Pseudomonas aeruginosa, Including High-Risk Clones, in an In Vitro Pharmacodynamic Model

A. Oliver, Ariadna Angulo-Brunet, P. Ambrose, 2020, Antimicrobial Agents and Chemotherapy.

Colistin plus meropenem combination is synergistic in vitro against extensively drug-resistant Pseudomonas aeruginosa, including high-risk clones.

A. Oliver, P. Ambrose, S. Luque, 2019, Journal of global antimicrobial resistance.

Apotransferrin in Combination with Ciprofloxacin Slows Bacterial Replication, Prevents Resistance Amplification, and Increases Antimicrobial Regimen Effect

R. Bonomo, K. Hujer, E. Skaar, 2019, Antimicrobial Agents and Chemotherapy.

Relationship between Gepotidacin Exposure and Prevention of On-Therapy Resistance Amplification in a Neisseria gonorrhoeae Hollow-Fiber In Vitro Infection Model

S. Bhavnani, P. Ambrose, Jianzhong Huang, 2020, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Piperacillin in an In Vitro Infection Model

Ronald N. Jones, M. Castanheira, S. Bhavnani, 2016, Antimicrobial Agents and Chemotherapy.

Characterization of the Pharmacokinetics-Pharmacodynamics of Tazobactam in 1 Combination with Piperacillin in an In Vitro Infection Model 2

Ronald N. Jones, M. Castanheira, S. Bhavnani, 2016 .

Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Ceftolozane in an In Vitro Infection Model

Ronald N. Jones, M. Castanheira, S. Bhavnani, 2013, Antimicrobial Agents and Chemotherapy.

Evaluation of Oral Tebipenem as a Step-Down Therapy following Intravenous Ertapenem against Extended-Spectrum β-Lactamase-Producing Escherichia coli in a Hollow-Fiber In Vitro Infection Model

S. Bhavnani, P. Ambrose, B. VanScoy, 2023, Antimicrobial agents and chemotherapy.

In Vivo Pharmacokinetics and Pharmacodynamics of ZTI-01 (Fosfomycin for Injection) in the Neutropenic Murine Thigh Infection Model against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa

D. Andes, P. Ambrose, A. Lepak, 2017, Antimicrobial Agents and Chemotherapy.

Exploration of the Pharmacokinetic-Pharmacodynamic Relationships for Fosfomycin Efficacy Using an In Vitro Infection Model

J. McCauley, S. Bhavnani, P. Ambrose, 2015, Antimicrobial Agents and Chemotherapy.

Relationship between Fosfomycin Exposure and Amplification of Escherichia coli Subpopulations with Reduced Susceptibility in a Hollow-Fiber Infection Model

J. McCauley, S. Bhavnani, P. Ambrose, 2016, Antimicrobial Agents and Chemotherapy.

Adjunctive transferrin to reduce the emergence of antibiotic resistance in Gram-negative bacteria

Eric P. Skaar, R. Bonomo, K. Hujer, 2019, The Journal of antimicrobial chemotherapy.

β-Lactamase inhibitors: what you really need to know.

M. Dudley, P. Ambrose, B. VanScoy, 2017, Current opinion in pharmacology.

Relationship between Ceftolozane-Tazobactam Exposure and Selection for Pseudomonas aeruginosa Resistance in a Hollow-Fiber Infection Model

Ronald N. Jones, M. Castanheira, J. McCauley, 2014, Antimicrobial Agents and Chemotherapy.

Pharmacological Basis of β-Lactamase Inhibitor Therapeutics: Tazobactam in Combination with Ceftolozane

Ronald N. Jones, J. McCauley, S. Bhavnani, 2013, Antimicrobial Agents and Chemotherapy.

Relationship between Ceftolozane-Tazobactam Exposure and Drug Resistance Amplification in a Hollow-Fiber Infection Model

Ronald N. Jones, M. Castanheira, J. McCauley, 2013, Antimicrobial Agents and Chemotherapy.

Pharmacodynamics of β-Lactamase Inhibition by NXL104 in Combination with Ceftaroline: Examining Organisms with Multiple Types of β-Lactamases

Ronald N. Jones, M. Castanheira, G. Drusano, 2011, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with 1 Cefepime in an In Vitro Infection Model 2 3 Running title : PK-PD of Tazobactam

D. Livermore, J. McCauley, S. Bhavnani, 2017 .

The Role of Pharmacometrics in the Development of Antimicrobial Agents

S. Bhavnani, P. Ambrose, B. VanScoy, 2018 .

Pharmacokinetic/pharmacodynamic considerations for new and current therapeutic drugs for uncomplicated gonorrhoea - challenges and opportunities.

M. Unemo, F. Franceschi, G. Drusano, 2020, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Women and Children Postexposure Prophylaxis in Pregnant Efficacy of Amoxicillin for Anthrax and Mathematical Modeling To Predict the Hollow-Fiber Pharmacodynamic Studies

G. Drusano, B. VanScoy, A. Louie, 2014 .

Hollow-Fiber Pharmacodynamic Studies and Mathematical Modeling To Predict the Efficacy of Amoxicillin for Anthrax Postexposure Prophylaxis in Pregnant Women and Children

Robert Kulawy, Arnold Louie, G. Drusano, 2013, Antimicrobial Agents and Chemotherapy.

Hollow Fiber Pharmacodynamic Studies and Mathematical Modeling

B. VanScoy, A. Louie, Weiguo Liu, 2013 .

Pharmacokinetic-Pharmacodynamic Target Attainment Analyses Evaluating Omadacycline Dosing Regimens for the Treatment of Patients with Community-Acquired Bacterial Pneumonia Arising from Streptococcus pneumoniae and Haemophilus influenzae

M. Huband, S. Bhavnani, P. Ambrose, 2023, Antimicrobial agents and chemotherapy.

Development of Modernized Acinetobacter baumannii Susceptibility Test Interpretive Criteria for Recommended Antimicrobial Agents Using Pharmacometric Approaches

D. Andes, S. Bhavnani, P. Ambrose, 2023, Antimicrobial agents and chemotherapy.

Meropenem Penetration into Epithelial Lining Fluid in Mice and Humans and Delineation of Exposure Targets

A. Oliver, G. Drusano, B. VanScoy, 2011, Antimicrobial Agents and Chemotherapy.

Comparative Efficacies of Candidate Antibiotics against Yersinia pestis in an In Vitro Pharmacodynamic Model

G. Drusano, B. VanScoy, A. Louie, 2011, Antimicrobial Agents and Chemotherapy.

Impact of Spores on the Comparative Efficacies of Five Antibiotics for Treatment of Bacillus anthracis in an In Vitro Hollow Fiber Pharmacodynamic Model

George L. Drusano, Arnold Louie, G. Drusano, 2011, Antimicrobial Agents and Chemotherapy.

Use of an In Vitro Pharmacodynamic Model To Derive a Moxifloxacin Regimen That Optimizes Kill of Yersinia pestis and Prevents Emergence of Resistance

G. Drusano, F. Sörgel, B. VanScoy, 2010, Antimicrobial Agents and Chemotherapy.

Dose Range Evaluation of Mycograb C28Y Variant, a Human Recombinant Antibody Fragment to Heat Shock Protein 90, in Combination with Amphotericin B-Desoxycholate for Treatment of Murine Systemic Candidiasis

G. Drusano, D. Stein, B. VanScoy, 2011, Antimicrobial Agents and Chemotherapy.

In vivo Pharmacokinetic/Pharmacodynamic (PK/PD) Target Characterization of the Novel, Long Acting Echinocandin CD101 against C. albicans and C. glabrata in the Neutropenic Murine Disseminated Candidiasis Model

D. Andes, P. Ambrose, A. Lepak, 2017, Open Forum Infectious Diseases.

In vivo pharmacodynamic characterization of a next-generation polyene, SF001, in the invasive pulmonary aspergillosis mouse model.

P. Ambrose, A. Lepak, B. VanScoy, 2024, Antimicrobial agents and chemotherapy.

Use of an In Vitro Pharmacodynamic Model To Derive a Linezolid Regimen That Optimizes Bacterial Kill and Prevents Emergence of Resistance in Bacillus anthracis

G. Drusano, F. Sörgel, B. VanScoy, 2008, Antimicrobial Agents and Chemotherapy.